Towards Healthcare
Antibody Discovery Market to Reach USD 20.71 Bn by 2034

Antibody Discovery Market Future Shaped by AI and Partnerships

Projections indicate that, the global antibody discovery market will increase from USD 8.31 billion in 2024 to USD 20.71 billion by 2034, experiencing a CAGR of 9.54% over the next 10 years. Rising prevalence of chronic and infectious diseases has estimated to drive the growth of the market. North America led the global market owing to the presence of major pharmaceutical and biotechnology companies, which is estimated to drive the growth of the antibody discovery market.

Content

  • Insight Code: 6207
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The antibody discovery market is worth USD 9.1 billion in 2025, and by 2034, it is forecasted to hit USD 20.71 billion, registering a CAGR of 9.54% over the decade.

North America is leading the antibody discovery market share by 40% due to the extensive collaborations, presence of leading market players, and strong academic research networks.

The antibody discovery market includes six segments including by technology, by type of antibody, by application, by service type, by end-user, and by region.

Key trends include the advancements in antibody formats, increasing investment & funding, and adoption of inorganic growth strategies.

The Antibody Society, Personalized Medicine Coalition, International Union of Immunological Societies, Government of Canada, National Institutes of Health (NIH), Food and Drug Administration, clinicaltrials.gov, GOV.UK
Any Questions